Zimmer Biomet Holdings, Inc. (NYSE:ZBH) manufacturer of musculoskeletal healthcare products and solutions, is reporting third quarter earnings results on Friday 6th November 2020, before market open.
The consensus estimates from Thomson Reuters are income of $ 1.07 per share.
For the full year, analysts predict revenues of $ 6822.19 million, while looking forward to income of $ 4.81 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 8,182.00 million ~ $ 8,262.00 million, where as bottomline are predicted in a range of $ 8.15 ~ $ 8.45 per share
Click Here For More Historical Outlooks Of Zimmer Biomet Holdings, Inc.
Previous Quarter Performance
Zimmer Biomet Holdings, Inc. recorded income for the second quarter of $ 0.05 per share, from the revenue of $ 1,226.00 million. The quarterly earnings dropped 97.41 percent while revenues declined 38.35 percent compared with the same quarter last year.
Wall street analysts are predicting, ZBH to report 2Q20 loss of $ 0.73 per share from revenue of $ 909.41 million. The bottom line results beat street analysts by $ 0.78 or 106.85 percent, at the same time, top line results outshined analysts by $ 316.59 million or 34.81 percent.
Stock Performance
Shares of Zimmer Biomet Holdings, Inc. traded up $ 2.55 or 1.86 percent on Thursday, reaching $ 139.35 with volume of 1.50 million shares. Zimmer Biomet Holdings, Inc. has traded high as $ 141.10 and has cracked $ 138.10 on the downward trend
According to the previous trading day, closing price of $ 139.35, representing a 83.95 % increase from the 52 week low of $ 74.37 and a 15.09 % decrease over the 52 week high of $ 161.11.
The company has a market capital of $ 28.85 billion and is part of the Healthcare sector and Medical Devices industry.
Recent Analyst recommendations
- On 12th October 2020, maintained by Raymond James at Strong Buy rating, with $ 170.00 target price.
- On 5th October 2020, maintained by SVB Leerink at Outperform rating, with $ 160.00 target price.
- On 11th September 2020, initiated by Wolfe Research at Outperform rating, with $ 174.00 target price.
Conference Call
Zimmer Biomet Holdings, Inc. will be hosting a conference call at 8:30 AM eastern time on 6th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.zimmerbiomet.in
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T.
